This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| HeLa | |
|---|---|
| Name | HeLa cell line |
| Organism | Human (Homo sapiens) |
| Cell type | Immortalized epithelial cells |
| Tissue | Cervical cancer |
| Origin | United States |
| Researcher | George Gey, Mary Kubicek, Jonas Salk |
| Year | 1951 |
HeLa HeLa cells are a line of immortalized human cervical cancer cells first propagated in 1951 from tissue collected at Johns Hopkins Hospital in Baltimore. The cells became foundational to modern biotechnology, virology, cancer research, pharmacology, and cell biology because of their robust growth, ease of culture, and susceptibility to infection and transformation. Their propagation influenced practices at institutions such as Rockefeller University, Massachusetts Institute of Technology, Cold Spring Harbor Laboratory, and National Institutes of Health.
In 1951, tissue from a patient at Johns Hopkins Hospital was taken during treatment at the Gynecology Service and brought to the laboratory of George Gey at the Johns Hopkins University School of Medicine where technicians including Mary Kubicek and colleagues isolated rapidly proliferating epithelial cells. The sample originated from a cervical tumor treated by surgeons at Johns Hopkins Hospital and involved pathologists and clinicians connected to Johns Hopkins Hospital Department of Gynecology. These cells were unusually resilient compared with contemporaneous cultures at laboratories such as Roswell Park Cancer Institute and Memorial Sloan Kettering Cancer Center, enabling distribution to research centers including Rockefeller University and Cold Spring Harbor Laboratory.
The cells derive from a poorly differentiated adenocarcinoma of the cervix and display features associated with malignant transformation observed in studies at Sloan Kettering Institute and Wellcome Trust. They exhibit rapid proliferation, anchorage-independent growth, high telomerase activity similar to findings attributed to Elizabeth Blackburn's and Carol Greider's telomere research, and aneuploid karyotypes characterized by cytogeneticists at Cleveland Clinic and University of California, San Francisco. HeLa cells support propagation of many human pathogens studied at Centers for Disease Control and Prevention, including adenoviruses, poliovirus strains used by Jonas Salk, and influenza isolates examined at Rockefeller University, making them models for cellular entry, replication, and immune response assays employed by labs such as Scripps Research and Howard Hughes Medical Institute investigators.
The cell line enabled mass production of poliovirus for the Polio vaccine efforts led by Jonas Salk and influenced trials coordinated with the National Foundation for Infantile Paralysis. They facilitated breakthroughs in cancer biology at Dana-Farber Cancer Institute and drug screening pipelines at Pfizer, Merck, and GlaxoSmithKline, and supported studies in gene expression leveraged by groups at Cold Spring Harbor Laboratory and Massachusetts Institute of Technology. HeLa cultures underpinned discoveries about cell cycle regulation explored by researchers at Cancer Research UK and European Molecular Biology Laboratory, assisted in the development of cell imaging techniques at Janelia Research Campus and European Synchrotron Radiation Facility, and contributed to cytogenetic mapping projects coordinated with Human Genome Project teams at Broad Institute and Wellcome Sanger Institute.
The procurement and use of the original tissue raised debates involving medical ethics centers such as Kennedy Institute of Ethics and regulations promulgated by bodies like the National Bioethics Advisory Commission and the Department of Health and Human Services. The lack of informed consent as understood today prompted legal and policy responses referenced in guidelines from the World Medical Association, the Declaration of Helsinki, and institutional review boards at Johns Hopkins University and Harvard Medical School. Advocacy groups including ACLU-affiliated advocates and bioethics scholars at Princeton University and Yale Law School have cited the case in discussions of patient autonomy, privacy, and research governance alongside cases involving Tuskegee syphilis study and Milgram experiment debates.
Questions about tissue ownership, commercialization, and privacy brought actions in forums that included analyses by scholars at Harvard Law School and University of California, Berkeley School of Law. Regulatory frameworks instituted by Food and Drug Administration and policy revisions at National Institutes of Health—such as controlled access to genomic data curated by the Database of Genotypes and Phenotypes and data-use committees—reflect responses to controversies involving commercialization by corporations like Thermo Fisher Scientific and licensing at institutions such as Columbia University and University of Pennsylvania. Court decisions and legislation in jurisdictions including Maryland and federal policies shaped consent practices influenced by precedents like cases adjudicated at the United States Supreme Court.
Dissemination of the cell line accelerated standardization efforts in culture methodology pursued by consortia associated with American Type Culture Collection and quality metrics developed at International Organization for Standardization laboratories. Practices for authentication, contamination control, and cell line provenance tracing became priorities at repositories such as ATCC, European Collection of Authenticated Cell Cultures, and biobanks at UK Biobank and Biobank Japan. This prompted adoption of mycoplasma testing, short tandem repeat profiling championed by groups at National Institute of Standards and Technology, and data-sharing policies advanced by Global Alliance for Genomics and Health.
The story has inspired works in journalism and the arts: investigative pieces in The New Yorker, features at The New York Times, and books authored by writers affiliated with Simon & Schuster and HarperCollins. It informed exhibits at museums including the Smithsonian Institution and Science Museum London, influenced biopolitical discourse in programs at United Nations Educational, Scientific and Cultural Organization, and was dramatized in documentaries produced by PBS and BBC. The case shaped public debates involving patient rights organizations like PatientsLikeMe, policy forums at World Health Organization, and scholarship across departments at Columbia University, Stanford University, and University of Oxford.
Category:Cell lines Category:Cancer research Category:Biomedical ethics